352 related articles for article (PubMed ID: 16973160)
1. Antisense oligonucleotide targeting c-fos mRNA limits retinal pigment epithelial cell proliferation: a key step in the progression of proliferative vitreoretinopathy.
Zhang L; Li X; Zhao M; He P; Yu W; Dong J; Liu G; Li C; Shi X
Exp Eye Res; 2006 Dec; 83(6):1405-11. PubMed ID: 16973160
[TBL] [Abstract][Full Text] [Related]
2. A c-myc antisense oligonucleotide inhibits human retinal pigment epithelial cell proliferation.
Capeáns C; Piñeiro A; Domínguez F; Loidi L; Buceta M; Carneiro C; Garcia-Caballero T; Sanchez-Salorio M
Exp Eye Res; 1998 May; 66(5):581-9. PubMed ID: 9628805
[TBL] [Abstract][Full Text] [Related]
3. Targeting of integrin-linked kinase with a small interfering RNA suppresses progression of experimental proliferative vitreoretinopathy.
Guo L; Yu W; Li X; Zhao G; Liang J; He P; Wang K; Zhou P; Jiang Y; Zhao M
Exp Eye Res; 2008 Dec; 87(6):551-60. PubMed ID: 18926819
[TBL] [Abstract][Full Text] [Related]
4. siRNA targeting mammalian target of rapamycin (mTOR) attenuates experimental proliferative vitreoretinopathy.
Zhou P; Zhao MW; Li XX; Yu WZ; Bian ZM
Curr Eye Res; 2007 Nov; 32(11):973-84. PubMed ID: 18027173
[TBL] [Abstract][Full Text] [Related]
5. HGF regulation of RPE proliferation in an IL-1beta/retinal hole-induced rabbit model of PVR.
Liou GI; Pakalnis VA; Matragoon S; Samuel S; Behzadian MA; Baker J; Khalil IE; Roon P; Caldwell RB; Hunt RC; Marcus DM
Mol Vis; 2002 Dec; 8():494-501. PubMed ID: 12500176
[TBL] [Abstract][Full Text] [Related]
6. Ribozyme to proliferating cell nuclear antigen to treat proliferative vitreoretinopathy.
Mandava N; Blackburn P; Paul DB; Wilson MW; Read SB; Alspaugh E; Tritz R; Barber JR; Robbins JM; Kruse CA
Invest Ophthalmol Vis Sci; 2002 Oct; 43(10):3338-48. PubMed ID: 12356843
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of human cytomegalovirus replication in a human retinal epithelial cell model by antisense oligonucleotides.
Detrick B; Nagineni CN; Grillone LR; Anderson KP; Henry SP; Hooks JJ
Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):163-9. PubMed ID: 11133862
[TBL] [Abstract][Full Text] [Related]
8. Effect of Robo1 on retinal pigment epithelial cells and experimental proliferative vitreoretinopathy.
Huang L; Xu Y; Yu W; Li Y; Chu L; Dong J; Li X
Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):3193-204. PubMed ID: 20071679
[TBL] [Abstract][Full Text] [Related]
9. Effect of 2'-benzoyl-oxycinnamaldehyde on RPE cells in vitro and in an experimental proliferative vitreoretinopathy model.
Lee JJ; Park JK; Kim YT; Kwon BM; Kang SG; Yoo YD; Yu YS; Chung H
Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):3117-24. PubMed ID: 12202537
[TBL] [Abstract][Full Text] [Related]
10. Changes in retinal gene expression in proliferative vitreoretinopathy: glial cell expression of HB-EGF.
Hollborn M; Tenckhoff S; Jahn K; Iandiev I; Biedermann B; Schnurrbusch UE; Limb GA; Reichenbach A; Wolf S; Wiedemann P; Kohen L; Bringmann A
Mol Vis; 2005 Jun; 11():397-413. PubMed ID: 15988409
[TBL] [Abstract][Full Text] [Related]
11. Active scatter factor (HGF/SF) in proliferative vitreoretinal disease.
Briggs MC; Grierson I; Hiscott P; Hunt JA
Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):3085-94. PubMed ID: 10967068
[TBL] [Abstract][Full Text] [Related]
12. Contrary effects of cytokines on mRNAs of cell cycle- and ECM-related proteins in hRPE cells in vitro.
Hollborn M; Reichenbach A; Wiedemann P; Kohen L
Curr Eye Res; 2004 Mar; 28(3):215-23. PubMed ID: 14977524
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of osteonectin by human retinal pigment epithelial cells is modulated by cell density.
Magee RM; Hagan S; Hiscott PS; Sheridan CM; Carron JA; McGalliard J; Grierson I
Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2707-11. PubMed ID: 10937587
[TBL] [Abstract][Full Text] [Related]
14. Galectin-1 influences migration of retinal pigment epithelial cells.
Alge CS; Priglinger SG; Kook D; Schmid H; Haritoglou C; Welge-Lussen U; Kampik A
Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):415-26. PubMed ID: 16384992
[TBL] [Abstract][Full Text] [Related]
15. C-Met antisense oligodeoxynucleotide inhibits growth of glioma cells.
Chu S; Yuan X; Li Z; Jiang P; Zhang J
Surg Neurol; 2006 Jun; 65(6):533-8; discussion 538. PubMed ID: 16720163
[TBL] [Abstract][Full Text] [Related]
16. Thrombin stimulates RPE cell proliferation by promoting c-Fos-mediated cyclin D1 expression.
Parrales A; Palma-Nicolás JP; López E; López-Colomé AM
J Cell Physiol; 2010 Feb; 222(2):302-12. PubMed ID: 19847806
[TBL] [Abstract][Full Text] [Related]
17. Assessment of the integrin alpha5beta1 antagonist JSM6427 in proliferative vitreoretinopathy using in vitro assays and a rabbit model of retinal detachment.
Zahn G; Volk K; Lewis GP; Vossmeyer D; Stragies R; Heier JS; Daniel PE; Adamis AP; Chapin EA; Fisher SK; Holz FG; Löffler KU; Knolle J
Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):1028-35. PubMed ID: 19815730
[TBL] [Abstract][Full Text] [Related]
18. The importance of Bcl-xL in the survival of human RPE cells.
Zhang N; Peairs JJ; Yang P; Tyrrell J; Roberts J; Kole R; Jaffe GJ
Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3846-53. PubMed ID: 17652760
[TBL] [Abstract][Full Text] [Related]
19. Overexpression p21WAF1/CIP1 in suppressing retinal pigment epithelial cells and progression of proliferative vitreoretinopathy via inhibition CDK2 and cyclin E.
Wang Y; Yuan Z; You C; Han J; Li H; Zhang Z; Yan H
BMC Ophthalmol; 2014 Nov; 14():144. PubMed ID: 25421815
[TBL] [Abstract][Full Text] [Related]
20. The properties of retinal pigment epithelial cells in proliferative vitreoretinopathy compared with cultured retinal pigment epithelial cells.
Abe T; Durlu YK; Tamai M
Exp Eye Res; 1996 Aug; 63(2):201-10. PubMed ID: 8983978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
